Indication
Acute Myeloid Leukemia with FLT3 Activating Mutations
1 clinical trial
4 products
Product
crenolanibProduct
cytarabineProduct
daunorubicinProduct
idarubicinClinical trial
A Safety and Tolerability Trial of Crenolanib and Chemotherapy With Cytarabine and Anthracyclines in Patients With Newly Diagnosed Acute Myeloid Leukemia With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2019-12-01